Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/06/2000 | WO2000018230A1 Combination of bisphosphonate and tetracycline |
04/06/2000 | WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
04/06/2000 | WO2000001835A3 Targeted integration into chromosomes using retroviral vectors |
04/06/2000 | WO2000001400A9 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof |
04/06/2000 | WO1999066936A9 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
04/06/2000 | WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein |
04/06/2000 | WO1999061453A3 priA |
04/06/2000 | WO1999061056A3 Methods and products for inducing mucosal immunity |
04/06/2000 | WO1999059525A9 Broad spectrum microbicidal and spermicidal compositions, devices, and methods |
04/06/2000 | WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
04/06/2000 | WO1999055730A3 Polyepitope carrier protein |
04/06/2000 | WO1999051748A9 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
04/06/2000 | CA2774207A1 Antibiotic compositions for treatment of the eye |
04/06/2000 | CA2659064A1 Antibiotic compositions for treatment of the ear and nose |
04/06/2000 | CA2346061A1 Carbohydrate vaccines for viral diseases |
04/06/2000 | CA2345959A1 Live virus vaccines to protect primates from hiv-1 infection and disease |
04/06/2000 | CA2345672A1 Antiviral purine derivatives |
04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
04/06/2000 | CA2345462A1 Treatment of hepatitis b infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
04/06/2000 | CA2345347A1 Methods for treating or preventing viral infections and associated diseases |
04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
04/06/2000 | CA2344578A1 Polistinae venom phospholipase |
04/06/2000 | CA2344466A1 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
04/06/2000 | CA2344104A1 Method of screening for large offspring syndrome |
04/06/2000 | CA2344050A1 Antibiotic compositions for treatment of the eye, ear and nose |
04/06/2000 | CA2343972A1 Ykl-40 as a marker and prognostic indicator for cancers |
04/06/2000 | CA2343965A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
04/06/2000 | CA2343927A1 Artemin, a novel neurotrophic factor |
04/06/2000 | CA2343098A1 Combination of bisphosphonate and tetracycline |
04/06/2000 | CA2342603A1 Antibiotic compositions for treatment of the eye, ear and nose |
04/06/2000 | CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto |
04/05/2000 | EP0990700A1 H. pylori fermentation process |
04/05/2000 | EP0990654A1 Substituted cyclobutylamine derivatives |
04/05/2000 | EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
04/05/2000 | EP0990001A1 Processes for production of immunoglobulin a in milk |
04/05/2000 | EP0989999A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
04/05/2000 | EP0989994A1 Streptogramines, their preparation and compositions containing them |
04/05/2000 | EP0989863A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
04/05/2000 | EP0989862A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent |
04/05/2000 | EP0989860A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules |
04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
04/05/2000 | EP0989851A1 Self-emulsifying formulation for acidic lipophilic compounds |
04/05/2000 | EP0595873B1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
04/05/2000 | EP0479866B1 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus |
04/05/2000 | CN1249781A Epitopes of protein pre-M/M of dengue virus, synthetic peptides |
04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
04/05/2000 | CN1249751A Substd. 2,4-diaminopyrimidines |
04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
04/05/2000 | CN1249175A Skin-protecting cosmetics |
04/05/2000 | CN1051096C Oligomers, their uses and formulations |
04/05/2000 | CN1051091C Method for detecting antibodies to hepatitis C virus |
04/05/2000 | CN1051090C Ganglioside GM3 analog having sialic acid residue fluorinated at 9-position |
04/05/2000 | CN1051084C Preparation of N-9 substd. guanine compounds |
04/05/2000 | CN1050999C Silkworm medicine for resisting viral silkworm diseases |
04/05/2000 | CN1050995C Elaboration of host defense mediators into biological fluids by systemic ds RNA treatment |
04/04/2000 | US6046355 Dihydropyrones with improved antiviral activity |
04/04/2000 | US6046238 Method for treating or preventing the spread of acne vulgaris |
04/04/2000 | US6046226 Administering to a patient an anti cryptococcus neoformans using dicationic bis/benzimidazole compounds; antifungal agents |
04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
04/04/2000 | US6046198 Hemoregulatory compounds |
04/04/2000 | US6046197 Non-peptide amide compounds; stimulate hematopoiesis and may be useful for treatment of viral, fungal and bacterial infectious diseases |
04/04/2000 | US6046175 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
04/04/2000 | US6046170 Therapeutic use of hemoglobin to treat head injury |
04/04/2000 | US6045999 Transcription factor E2F-4 |
04/04/2000 | US6045832 Use of DACEE and Derivatives for treating viral diseases |
04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
04/04/2000 | US6045820 Iodinated strong base anion exchange resin antiseptic particles attached to a carrier material whereby the antiseptic leaves no halogen residue in sterilized fluid or bodily wound sites |
04/04/2000 | US6045815 An antifungal composition including a dipolar aprotic solvent and an aqueous secondary solvent |
04/04/2000 | US6045805 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
04/04/2000 | US6045803 Administering to an avian a recombinant herpesvirus of turkeys for expressing an antigenic polypeptide to treat viral diseases |
04/04/2000 | US6045802 Antitumor agents treating cancer |
04/04/2000 | US6045798 Membrane-associated immunogens of mycobacteria |
04/04/2000 | US6045795 Methods and compositions for ameliorating the symptoms of sepsis |
04/04/2000 | CA2204739C Macrocyclic lactone compounds and their production process |
04/04/2000 | CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins |
04/04/2000 | CA2031129C Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
03/30/2000 | WO2000017644A1 Ndp |
03/30/2000 | WO2000017387A1 Production and use of antimicrobial agents |
03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
03/30/2000 | WO2000017361A2 Interferon-epsilon |
03/30/2000 | WO2000017358A2 Human chaperone proteins |
03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
03/30/2000 | WO2000017354A1 Human isre-binding protein |
03/30/2000 | WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
03/30/2000 | WO2000017222A1 31 human secreted proteins |
03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
03/30/2000 | WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
03/30/2000 | WO2000017175A1 INHIBITORS OF p38 |
03/30/2000 | WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
03/30/2000 | WO2000017159A1 Arylsulfonanilide ureas |
03/30/2000 | WO2000016803A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
03/30/2000 | WO2000016802A1 Hepatitis b core antigen nucleic acid vaccine |
03/30/2000 | WO2000016793A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |